Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-01-05

Clinical Trial Update: Effects of Left Atrial Appendage Occlusion

View source ↗

Summary

A clinical trial investigating left atrial appendage occlusion for atrial fibrillation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Pittsburgh | Conditions: Atrial Fibrillation | Status: WITHDRAWN